Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Kornélia Polyák, Michael R. McKeown et al.|Nature|2016Cited by 629
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast CancerShaokun Shu, Kornélia Polyák, Hua‐Jun Wu et al.|Molecular Cell|2020Cited by 207
Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironmentsMichalina Janiszewska, Kornélia Polyák, Doris P. Tabassum et al.|Nature Cell Biology|2019Cited by 163
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical OutcomesAndriy Marusyk, Kornélia Polyák, Doris P. Tabassum et al.|Cancer Research|2016Cited by 140
JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell StatesLaura E. Stevens, Kornélia Polyák, Guillermo Peluffo et al.|Cancer Research|2022Cited by 101